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The genus Mycobacterium is diverse, ranging from slow-growing human 
pathogens such as M. tuberculosis to fast-growing saprophytes such as M. smegmatis. M. 
ulcerans is the causative agent of the neglected disease known as Buruli ulcer, an 
emerging pathogen first described in Buruli County, Uganda. Antibiotic resistance among 
Mycobacterial pathogens is growing at an alarming rate and is creating an urgent need for 
novel diagnostic and therapeutic approaches. Elucidating the details of virus/host 
interactions among the mycobacteria and their phages thus has the potential to affect how 
we think about the role of these bacteria in both clinical and environmental settings.  
Towards this end, we are analyzing the complete genome sequence of 654 
mycobacteriophages isolated on Mycobacterium smegmatis mc
2
155. Here we report on 
six novel bacteriophages from Ugandan soil, in addition to three bacteriophages isolated 
from American soil, and using pairwise nucleotide identity and phamily composition of 
the genomes work to elucidate the genomic determinants for their ability or inability to 






Buruli ulcer, a disease caused by Mycobacterium ulcerans, is now considered a 
neglected tropical disease by the World Health Organization (WHO) and is resulting in 
significant economic and social impact (Hamzat & Boakye-Afram, 2011; World Health 
Organization, 2012a). This disease leads to large skin lesions that are generally found on 
the arms and legs of patients. Before the ulcerative stage of the infection a painless 
nodule appears. The ulcerative stage leads to still painless lesions that may reach the 
bone. The recommended treatment is a long-term combination of antibiotics including 
floroquinolones and rifampicin as well as surgical debridement and grafting (O'Brien et 
al., 2012). While these treatments have been reasonably successful in the treatment of 
Buruli ulcer they are not always feasible, due primarily to the fact that Buruli ulcer is 
most prevalent in poor and rural communities in Africa and Latin America. Early 
diagnosis is important to successful treatment with antibiotics, but because of the rural 
location of most patients antibiotics are often not accessible early enough, if at all.  In 
areas most affected by Buruli ulcer, etiology is also often attributed to mystical causes, 
leading individuals first to seek traditional healers, and then medical treatment when it is 
too late, leaving disfiguring surgery as the only option (Peeters Grietens et al., 2012). 
Treatment is also often avoided due to the reputation of the surgery causing greater 





 M. ulcerans pathogenesis is still unclear, making diagnosis of Buruli ulcer 
difficult (World Health Organization, 2012a). In addition to difficulty in treatment Buruli 
ulcer remains difficult to diagnose early. In addition the painless lesions, and 
disfigurement associated with treatment result in Due to M. ulcerans slow doubling time, 
culturing the bacteria takes six to eight weeks. While PCR remains the gold standard for 
diagnosis, it remains difficult due to the high cost, reliance on trained professionals, and 
availability of laboratory equipment.  
Mycobacterium Tuberculosis and Leperae   
In addition to M. ulcerans, the genus Mycobacterium also includes 
Mycobacterium tuberculosis and Mycobacterium leprae. According to the WHO, in 2012 
there were an estimated 8.7 million new cases of tuberculosis, leading to 1.4 million 
deaths (World Health Organization, 2012b). M. leprae has been characterized as having 
an intracellular lifestyle, infecting macrophages, and Schwann cells of neurons (Bhat & 
Prakash, 2012). M. tuberculosis also resides within macrophages of the alveoli of the 
lung; within these cells fusion of the phagosome with the lysosome is inhibited, inhibiting 
lysis and allowing the pathogen to evade the immune system and persist within the cell 
(Wong, Chao, & Av-Gay, 2012). One way in which M. tuberculosis and M. leprae 
become intracellular is through the use of complement receptors and mannose receptors 
to mediate their entry into macrophages (Van der Werf, Van der Graaf, Tappero, & 








While M. tuberculosis and M. leprae are intracellular pathogens, M. ulcerans is an 
extracellular pathogen (Yeboah-Manu et al., 2006). M. ulcerans has been shown to live 
an extracellular life due to the loss of the ESX-1 protein secretion system, and 
antiphagocytic properties of mycolactone (the toxin secreted by M. ulcerans) (Stinear et 
al., 2007a). This means that the bacteria can be more easily accessed for treatment.  
 The genomes of clinical isolates have been sequenced revealing that M. ulcerans 
consists of a 5632 kb circular chromosome and a plasmid pMUM001 that is 174 kb. The 
plasmid has a G+C content of 62.5% and contains 81 protein coding sequences (Stinear 
et al., 2007b). Comparative genomics has shown that M. ulcerans likely evolved over a 
million years ago from the fish pathogen progenitor M. marinum, having 98% nucleotide 
similarity (Stinear, Jenkin, Johnson, & Davies, 2000). Further analysis has shown that 
divergence likely occurred with the acquisition of the pUMUM001 plasmid encoding for 
a mycolactone that is responsible for the phenotypic differences from M. marinum (Doig 
et al., 2012). Mycolactone is the immunosuppressive polyketide toxin that is responsible 
for the pathogenesis associated with infection with M. ulcerans, and is believed to have 
given M. ulcerans the ability to cause this global neglected disease, Buruli ulcer (George, 
Barker, Welty, & Small, 1998).   
Mycobacteriophages 
 Bacteriophages are viruses that infect bacteria, and are estimated to be the most 
abundant biological entities on planet earth with an estimated 10
31 
particles globally 





undergo one of two lifestyles. In the lytic cycle replication begins immediately upon 
infection of the cell, leading to rapid lysis of the bacterial host. Alternatively, in the 
lysogenic cycle bacteriophages may integrate into the host genome and persist for 
generations before beginning active replication and lysis of the host cell, this is believed 
to be primarily due to the state of the bacterial cell but the clear mechanism is not yet 
defined.  
Mycobacteriophages specifically are viruses that infect mycobacterial hosts. 
Currently there are 654 completely sequenced Mycobacteriophage genomes, each of 
which was isolated using the non-pathogenic Mycobacterium smegmatis as a host (Henry 
et al., 2010). This work has been largely due to the SEA-PHAGES program, a course 
sponsored by the Howard Hughes Medical Institute (HHMI) to help encourage 
undergraduate involvement in research (Hatful et al., 2006). Sequenced and annotated 
genomes have been compiled into a single database allowing for bioinformatic analysis. 
Effective bioinformatic tools are becoming more important due to the improvements in 
technology making sequencing more efficient and cost effective. Even as the number of 
sequenced mycobacteriophage genomes increases, the data continue to reveal a higher 
than estimated diversity, as well as “mosaic” genome structure (Pedulla et al., 2003).  
Phamerator, a bioinformatic software application, uses pairwise comparisons to 
sort protein-coding genes into “phamilies” of related sequence (Cresawn et al., 2011). 
Creation of genome maps allows for visualization of relatedness between phages, as well 
as analysis of different evolutionary histories of individual genes of these mosaic 
genomes. Using Phamerator, the mycobacteriophage genomes within the current database 





identity and protein family composition. Currently Mycobacteriophages are divided in to 
18 clusters, given alphabetic designation, and further divided in to 28 subclusters, noted 
by a numeric designation. Phages within a specified cluster have highly conserved 
genomes, whereas when comparing phages between clusters there may be little similarity 
(Figure 1.). Bioinformatic analysis can be utilized to gain further understanding of the 
mechanisms behind host restriction in M. ulcerans. Even among phages from the same 
subcluster, gene content and host range phenotypes vary considerably.  While the genetic 
basis of host range remains unclear, a correlative study of gene content and host range is 

















Figure 1. Phages within a cluster are closely related, while phages in two different clusters have little or no recognizable similarity. Phages 
D29 and L5 represent phages from subcluster A2. Containing many similarities as denoted by the colors between the genome maps. Phages 
BPs and Halo are both cluster G phages and as noted by the purple showing the highest level of conservation. While both cluster A and both 
cluster G phage are closely related within their respective clusters, conservation is not observed between cluster A and G. (Colors between 
maps represent level of similarity with the no similarity is shown by white while lowest is red, followed by orange, yellow, green, blue, indigo, 






Phage therapy, or the use of bacteriophages in the treatment of bacterial infections 
is not a new idea, and may hold immense potential with the threat of a post-antibiotic era. 
In the early 1900s, Felix d’Herelle and Fredrick Twort independently discovered 
bacteriophages. Felix d’Herelle immediately recognized their potential, and soon after 
their discovery bacteriophages were used to treat dysentery, cholera, bubonic plague and 
staphylococcus skin infections (Summers, 1999). Many of these early trials have received 
much criticism from the west due to their lack of documentation or credibility. In 
addition, by the mid 1900’s and the emergence of antibiotics, the idea was abandoned by 
the Western medicine.  
While the Western world has turned away from phage therapy, its use has 
continued in Eastern European and former Soviet Union countries. The Eliava institute of 
Tbilisi, Georgia is known as one of the leaders in phage therapy having continually used 
phage therapy in the clinic since the 1900s (http://www.eliava-institute.org). Although 
phage therapy is not being used in the most traditional sense in the Western world, 
several companies are using bacteriophage preparations in other novel ways including 
preparations that have been approved by the FDA for the treatment of surfaces in food 
processing facilities (http://www.intralytix.com). Additionally, bacteriophages are being 
explored in diagnostics, especially in very-slow growing or difficult to culture bacterial 
strains.  
 Several aspects of bacteriophages make them attractive therapeutic use, including 




host), they are self-limiting in that they require their specific bacterial host to replicate, 
and they are able to replicate at the site of infection due to the presence of the specific 
host (Clark & March, 2006). M. ulcerans has demonstrated resistance to antibiotics 
including rifampicin, and while in the future resistance to bacteriophages could also be 
observed, there are an estimated 10
31 
bacteriophage particles globally (Wommack & 
Colwell, 2000). Mixed populations of mycobacteriophages that infect M. ulcerans could 
be used, offering a potentially large number of combinations for therapy. The need for an 
affordable and accessible novel treatment of M. ulcerans is great and due to its localized 
infection, extracellular life cycle, and poor response to current treatments, bacteriophage 
therapy could be feasible.  
II Host Restriction in Bacteriophage Infection 
Current Data 
 While genomic data for mycobacteriophages are increasing dramatically, host 
range information is still limited. The only research currently published pertaining to M. 
ulcerans host rang evaluated this host’s capacity to support replication of fourteen 
Mycobacteriophages. Four of which infected M. ulcerans (Rybniker J,Kramme S., Small 
P.L., 2005).  Of these four bacteriophages, three were from cluster A, with bacteriophages 
D29 and L5 belonging to cluster A2 and bacteriophage Bxz2 belonging to cluster A3. The 
fourth phage, TM4, belongs to cluster K2. All four bacteriophages also demonstrated the 
ability to infect two different strains of M. tuberculosis. While phages from cluster A 
appear to have an advantage in infecting M. ulcerans, it is important that additional 




range can differ significantly at even the sub cluster designation. This will help gain a 
greater insight to weather some specific clusters actually infect M. ulcerans more readily 
than others. In a second host range paper by Deborah Jacobs-Sera et.al, phages that are 
able to infect M. tuberculosis were investigated, finding that cluster K and subcluster A2 
and A3 appear to most readily infect M. tuberculosis (Jacobs-Sera et al., 2012). Phages 
utilized in this study are included in the Mycobacteriophage database accessed by 
Phamerator.  Results also indicate that host restriction is likely through single residue 
substitutions in tail proteins (Jacobs-Sera et al., 2012). Phages from cluster A2, A3, K and 
G all show an ability to infect the genus Mycobacterium.  While the viral particles 
viewed with a transmission electron microscope are similar, the gene content is highly 
varied. Both of these papers indicate a potential correlation between cluster and host 
range restriction in the genus Mycobacterium. Furthermore. We propose a study of a 
broad phage collection like Jacobs-Sera using the host M. ulcerans. 
Host restriction at Adsorption  
The first step of infection by a bacteriophage is attachment to the host cell, also 
known as adsorption. This attachment of the phage receptor binding protein is imperative 
for subsequent injection of the viral DNA into the host therefore, attachment is believed 
to be one of the largest determinants in bacteriophage infection (Henry & Debarbieux, 
2012; Moldovan, Chapman-McQuiston, & Wu, 2007). In one Escherichia coli 
bacteriophage, adaption to new phage binding receptors has been observed, 
demonstrating that when a primary receptor is not available, the bacteriophage is able to 
target a secondary receptor on the cell (Meyer et al., 2012). We therefore propose that 




of mycobacteriophages. The Mycobacterial cell membrane of gram-negative bacteria 
contains a high level of various lipids. Cell membrane content not only differs between 
genera, but also by species. One example of this is arabinogalactan (AG), a lipid specific 
to Mycobacteria.  Slow growing mycobacteria also contain the phthiocerol lipid family, 
which is not observed in fast-growing Mycobacteria (Guenin-Mace, Simeone, & 
Demangle, 2009). One study demonstrated the importance of glycolipid molecules for 
attachment of phage in M. smegmatis, predicting that phage binding capacity could be to 
strain-specific glycolipid antigens (Khoo et al., 1996). In addition, the unique 
mycolactone expressed in M.ulcerans could potentially play a similar role in host 
restriction. The host range could be limited, not only by the specificity of these receptors, 
but also by mutation in the tail fibers, which could prevent binding, and therefore 
subsequent productive infection. 
Host Restriction of Infection 
 Host restriction is not only observed in the initial adsorption stage, but also during 
the stages of infection through various bacterial defense methods including Clustered, 
Regularly Interspaced Short Palindromic Repeats (CRISPRs), toxin anti-toxin systems 
and restriction endonucleases. Host restriction has been observed where Clustered 
Regularly Interspaced Short Palindromic Repeats CRISPRs are present. These systems 
offer a horizontally-acquired, but heritable “adaptive” immunity for bacteria and are 
composed of CRISPR loci and CRISPR associated or cas genes (Richter, Chang, & 
Fineran, 2012). In this system the CRISPR loci contain short non-repetitive DNA 
stretches that were likely derived from the invading bacteriophage genome. This allows 




cleavage of the bacteriophage DNA (Deveau et al., 2008). While CRISPR systems have 
been shown to play a powerful role as the bacterial defense, this is not likely to contribute 
to host restriction in M. ulcerans due to the fact that no defined CRISPR or CRISPR 
associated (Cas) Systems have been identified in this host. 
Toxin-antitoxin systems could play a potential role in host restriction. In these 
systems, toxins are produced along with antitoxins that are capable of neutralizing the 
toxin in normal situations. When the cell undergoes stress, such as infection by a phage, 
the antitoxin can readily degrade. Upon degradation the toxin accumulates and acts to 
induce cell death (Yamaguchi, Park, & Inouye, 2011). These systems have been identified 
in systems in which a plasmid relies on the constant production of an anti-toxin, if 
production of the anti-toxin stops the cell may then die due to accumulation of the toxin 
without the complementary anti-toxin therefore stabilizing the plasmid in the cell 
(Frampton, Aggio, Villas-Boas, Arcus, & Cook, 2012). While these systems could 
effectively restrict host range, it is at the population level rather than conferring a benefit 
to an individual cell. This leads us to ask the question: is the cost of phage infection 
higher than death of an individual cell?  While more than 60 toxin-antitoxin systems have 
been identified in M. tuberculosis, there are not any currently identified in M. ulcerans. 
Other possible means of host restriction include restriction endonucleases. 
Restriction endonuclease systems are commonly observed in bacteria and are able to 
restrict the host range by targeting and cleaving specific sequences with the invading 
bacteriophage genome, terminating the infection of the host (Bickle & Kruger, 1993). 
Bacteriophages are not likely contain restriction sites specific to their bacterial host, 




advantage in infecting that specific bacterium (Kruger & Bickle, 1983). Several potential 
restriction endonuclease-like proteins have been identified within the M. ulcerans 
genome (Stinear et al., 2007a). These restriction enzymes could potentially target specific 
sequences in phage DNA for degradation before they are able to replicate within the cell.  
While this system of restriction may be observed in M. ulcerans enzymes 
involved are not well characterized and are not believed to play a large role in host 
restriction.  
III Specific Aims 
This research aims to add to the current host range data available for 
mycobacteriophages, specifically for the host M. ulcerans. This was achieved by first 
identifying novel phages that have the ability to infect M. ulcerans. These novel phages 
were isolated from soil using a mycobacterium lab strain Mycobacterium smegmatis 
(mc
2
155) and then tested using the M. ulcerans host.  A second aim was to sequence and 
annotate a portion of novel phages using next generation sequencing techniques and 
annotation tools. The final aim was to use bioinformatics to further define host range in 
M. ulcerans. In addition to the novel environmental isolates, other mycobacteriophages 
from various geographical regions as well as other mycobacteriophages that have already 
been sequenced were also obtained and used for testing on the M. ulcerans host.  
We propose that bioinformatic comparisons can be used to predict host range 
phenotypes of mycobacteriophages. By comparison of the two subsets of gene content 
data for bacteriophages with a phenotype able to infect vs. unable to infect the host within 




host range. Identification of point mutations within these tail fiber proteins can be further 
investigated in the lab by restoring mutations, thereby restoring the ability of that phage 
to infect M. ulcerans. A genome wide-association approach was used to investigate 
further conservation within phages that are able to infect M. ulcerans. Using 
bioinformatics to guide further laboratory investigation, we aim to develop an increased 
understanding of M. ulcerans host range, allowing for the incorporation of host range 






Two M. ulcerans strains were obtained as a gracious gift from Pamela Small 
(University of Tennessee). M. ulcerans 1615 is a pathogenic clinical isolate from a  
Malaysian patient (American Type Culture Collection 35840), and M. ulcerans 118 is a 
derivative that is lacking in the pMUM001 virulence plasmid (Stinear et al., 2004).  Both 
M. ulcerans strains were grown at 30° C for 1-3 months on 10% OADC enriched 
Middlebrook 7H10 agar. Liquid cultures were made by passaging cells from plates in 
10% OADC enriched Middlebrook 7H9 media and incubated at 30° C while shaking at 
50 RPM for 1-2 weeks. Mycobacterium smegmatis mc
2
155 (Snapper, Melton, Mustafa, 
Kieser, & Jacobs, 1990) was used for isolation of novel phages. M. smegmatis was grown 
on Middlebrook 7H10 agar 10% ADC, at 37° C shaking at 250 rpm for 24-48 hours. 
Carbenicillin (50 g/ml) and cycloheximide (10 g/ml) were added to all media. 
Bacteriophages 
 All novel bacteriophages were isolated by enrichment of soil samples with M. 
smegmatis for 24 hours before plating on top agar overlays as described below. Putative 
plaques were then selected and subjected to repeated plaque purification through a series 
of plating until plaque morphology indicates a single phage population. All 
mycobacteriophages were propagated using M. smegmatis to generate high titer lysates. 
This was achieved by seeding top agar overlays with 500 l M. smegmatis and plating 




mM NaCl; 1 mM CaCl2). Lysates were collected by flooding, collecting, and filtering 
phage buffer from high titer plates.  
Amplification Assay 
To rapidly identify phages that have the ability to infect the M. ulcerans host, a 
phage amplification assay was preformed as outlined by Small (Rybniker J,Kramme S., 
Small P.L., 2005).  Phages tested included unsequenced novel phages as well as a 
collection of previously sequenced phages obtained as a generous gift from Graham 
Hatfull (University of Pittsburgh). D29 was used as a positive control bacteriophage 
capable of infecting M. ulcerans (Rybniker J,Kramme S., Small P.L., 2005). The 
amplification assay was preformed by adding 50l of each phage tested to 50l of 
bacterial culture at an OD of 0.6. Each phage was diluted such that the final concentration 
in the infection was 10
7
 pfu/ml, establishing a multiplicity of infection  (MOI) of 1. 
Infection was allowed to take place at 30° C for 90 min (Giri, Bhowmik, Bhattacharya, 
Mitra, & Das Gupta, 2009). After infection exogenous phage particles were deactivated 
using 2 mM ferrous ammonium sulfate (FAS) as previously described (McNerney et al., 
1998). After vigorous vortexing and incubation at room temperature for 5 min, 20l of 
each amplification product was plated on top agar overlays seeded with 500 l M. 
smegmatis and incubated for 24 hrs at 37° C. 
DNA Sequencing  
Genomic DNA was prepared for next generation sequencing by first obtaining 10 
ml of high titer lysate prepared by infecting lawns of M. smegmatis and incubating at 37° 




incubate overnight at 4°C. Bacteriophage particles were then filtered through a 0.22 μm 
filter to remove any bacterial cells. DNAse was then added to degrade any bacterial 
DNA. After incubation with DNAse at 37° C phage particles were separated from the 
mixture using polyethylene glycol precipitation and centrifugation. Bacteriophages were 
then resuspended in buffer and the DNA was extracted using guanidinium thiocyanate 
and syringe-mounted columns (Promega Wizard
®
 Genomic DNA Purification Kit.). 
Genomic DNA was quantified using a standard fluorometer assay.  
A bar-coded 200 bp DNA library was then prepared using enzymatic shearing 
(IonXpress
TM
 Plus gDNA Fragment Library Preparation kit). Appropriate sized fragments 
were size selected using the E-Gel® SizeSelect
TM
 Agarose Gel. The sample libraries were 
equalized using the Ion Library Equalizer
TM
 Kit before templating and sequencing. This 
was achieved using the Ion torrent Personal Genome Machine (PGM) with an Ion 314
TM
 
chip, and the Ion PGM
TM
 Template OT2 200 templating and sequencing kits. 
Bioinformatics    
Genomic sequence was assembled using the GS de Novo assembler. After the 
genomes were assembled they were annotated using gene prediction and annotation 
software including DNA Master, GeneMark, and Gene Locator and Interpolated Markov 
ModelER (GLIMMER). These genomes were then added to the existing Mycobacterium 
database in Phamerator. This was achieved by assigning protein families to each gene 
using nucleotide blast alignments with an evalue threshold of 1 x 10
-5
. Proteins with no 





Isolation of novel bacteriophages 
 
Six novel mycobacteriophages were isolated from soil samples obtained from 
Ugandan soil taken from three locations in Gulu, Uganda (GPS coordinates 2.788194, 
32.305600, 2.788194, 32.305637 and 2.775200, 32.290647) (figure 2).  The names 
given to these bacteriophages are Espe, Naomi, Gloria, Mercy, Fatuma and Aloyo. All 
phages produced clear plaques on M. smegmatis (Figure 3).  
 
 
Figure 2. Map of Uganda showing were soil samples were collected (Red pin), in relation to 







                                               
                                    
 
Figure 3. Plaque assay of Espe showing the large clear plaques plated on M. smegmatis 
mc2155 (shown by the arrow). Naomi, Gloria, Mercy, Fatuma and Aloyo also produced clear 
plaques of similar sizes.  
 
 
In addition four other phages were isolated from soil from Harrisonburg, 
Virginia through collaboration with undergraduate students. These phages also 
isolated on M. smegmatis mc2155 were named Lauren 3(1),Burke, OrionPax and 
Rover14. OrionPax produced halo-like plaques, while Lauren 3(1), Burke and 
Rover14 all produced clear plaques similar to those of the phages isolated from the 
Ugandan soil.  
Optimization of the Amplification Assay:  
 
 Pathogenic and non-pathogenic M. ulcerans strains were first plated on 7H9 
with 10% OADC before suspensions were made for use in the assay. Inoculation of 
liquid media was not effective in growth of liquid cultures (Figure 4). In order to 
obtain liquid cultures with an optical density of 0.6, suspensions of M. ulcerans 118 





                 
                                   
 
Figure 4. M. ulcerans liquid culture grown for one year at 30° C. Shaking at 50 RPM. Cell 
growth produces colonies that adhere to the flask rather than producing a turbid culture.   
 
 
                                          
 
Figure 5. Resuspension of M. ulcerans cells to produce a culture with an optical density of 0.6 at 
600 nm. After passage of colonies grown in liquid culture through a 25 gauge needle, the culture 






 Elimination of exogenous phages with ferrous ammonium sulfate (FAS) at a 
molarity of 2 mM was shown effective using M. smegmatis mc
2
155 and D29. Infections 
with a ratio of one bacterial cell to one bacteriophage, or an MOI of one were used, and 
infection proceeded for 100min. When no bacterial cells were are added, all phages were 
successfully eliminated, while when bacterial cells were added successful infection 
occurred on the indicator plate. When no FAS was added initial added, as well as those 
produced by infection are plated on the indicator plate (figure 6). 
                                    
 
Figure 6. Elimination of exogenous phage particles with 2mM FAS and a MOI: 1 with D29. 
Top row: M. smegmatis mc2155- D29+ FAS+. Middle row: M. smegmatis mc2155+ D29+ FAS+ 
(6-fold dilutions from left to right) Bottom row: M. smegmatis mc2155 + D29+ FAS- (6-fold 






Control amplification assays were preformed with D29 and Rosebush, both 
isolated and able to infect M. smegmatis mc2155.  D29 was also used as a positive 
control in the M. ulcerans 118 strain while Rosebush was used as a negative control 
for M. ulerans 118 as described by Pam Small (Figure 7 & 8). It should be noted that 
in the M. smegmatis mc2155 plate the amplification product ran, resulting in the 
smeared appearance, as compared to the spots typically seen. Infections were at a 
MOI of one and allowed to precede for 100 min before deactivation with 2 mM FAS. 
 
                       
Figure 7. Amplification assay with M. ulcerans118, 2mM FAS, MOI: 1 and 100 min infection 
time. Top row: Negative control Rosebush, Left: M. ulcerans 118 and Rosebush + no FAS, 
middle: M. ulcerans 118 – Rosebush + FAS +, Right M. ulcerans 118 and Rosebush + FAS +. 





                                      
  
Figure 8. Amplification assay with M. smegmatis mc
2
155, 2mM FAS, MOI:1 and 100 min 
infection time. Top row: Negative control Rosebush, Left: M. smegmatis mc
2
155 and Rosebush + 
no FAS, middle: M. smegmatis mc
2
155– Rosebush + FAS +, Right M. smegmatis mc
2
155 and 
Rosebush + FAS +. Bottom row: same as above with positive control bacteriophage D29.  
 
Sequence of novel bacteriophages 
 
Genomic DNA was isolated from Espe, Naomi, OrionPax, Rover14 and Burke. 
The concentration of the genomic DNA was then calculated using a standard 
fluorometer. Espe had a concentration of 114.97 ng/μl, Naomi 14.70 ng/μl, OrionPax 
276.50 ng/μl, Rover14 302.83 ng/μl and Burke 139.45 ng/μl. 
 After creation of the 200bp library by enzymatic shearing the individual 




library concentration as calculated using the qubit ion sphere quality control kit was 
3.31%. The library was then run on two 314 ion chips.  
The first run produced 183,217 total sequencing reads with a mean length of 
216 base pairs. Ion sphere particles (ISP) were loaded in to 39% of the wells on the 
314 ion chip with 80% enrichment and 86% clonal spheres (Figure 9). Of the total 
reads, 26,273 corresponded to the Espe genome, 9,296 to Rover14, 22,388 to Burke 
and 123,994 to OrionPax (figure 10). In the second run 114,859 total reads were 
sequenced with a mean length of 188 base pairs. 25% of the wells on the second 314 
ion chip were loaded with ISP’s with a 79% enrichment and 86% clonal spheres. In 
this run 16,211 sequencing reads corresponded to the Espe genome, 6,105 to 







Figure 9. Loading metrics from the Ion Torrent PGM for the first run of Espe, Rover14, Burke and OrionPax. Ion Sphere Particle (ISP) loading density of the 314 chip is 
shown on the left where blue indicates a low ISP density and red indicating the highest ISP density. Center panel shows information regarding the ISPs and weather they 










Figure 10. Sample-specific metrics retrieved by barcode for run one on the Ion Torrent PGM of Espe, Rover14, Burke and OrionPax. For each sample the 











Figure 11. Loading metrics from the Ion Torrent PGM for the second run of Espe, Rover14, Burke and OrionPax. Ion Sphere Particle (ISP) loading 
density of the 314 chip is shown on the left where blue indicates a low ISP density and red indicating the highest ISP density. Center panel shows 














Figure 12. Sample specific metrics for run two on the Ion Torrent PGM of Espe, Rover14, Burke and OrionPax. For each sample the 







Each genome was assembled using the GS de Novo assembler. Espe, OrionPax 
and Rover14 each assembled in to a single contig of 51,099 base pairs, 75,059 base pairs 
and 41,440 base pairs respectively. Burke assembled into four contigs of 134,463 base 
pairs, 13,599 base pairs, 4,355 base pairs and 2,680 base pairs.  
The average depth of coverage for each of the genomes was then calculated. 
OrionPax had the greatest depth of coverage with 526, while Espe had an average depth 
of coverage of 158 and Rover14 had an average depth of coverage of 65.  
 
Bioinformatic Analysis 
 Annotations were completed for Espe and OrionPax. The Espe genome was 
determined to have GC content of 63.85% and 100 genes. Twenty of these genes were 
assigned putative functions based on BLAST, HHpred, and RPS-BLAST searches. This 
genome belongs to the mycobacteriophage cluster A1. 
 OrionPax has a GC content of 63% and 143 genes, with 30 where function could 
















Figure 13. Phamerator genome maps for Espe and OrionPax. The left end of each genome is shown. Genes are displayed as colored boxes 








Isolation of novel Bacteriophages 
  
 While not all of the novel phages isolated have been sequenced, the five 
unsequenced phages have been archived for use in subsequent experiments and will 
be tested on the M. ulcerans host.  These phages are particularly valuable because 
they were isolated from Gulu Uganda, which is near where Buruli ulcer was first 




Due to several factors, the amplification assay method to test bacteriophages on 
M. ulcerans has proven to be more difficult than expected, and has not given reproducible 
results for most tested phages. One limitation of this method is the host its self. M. 
ulcerans is notoriously difficult to culture, and our experiences are consistent with this. 
With a doubling time of 30-80 hours it is a very slow growing organism. In addition to 
the slow growth, cells also tend to clump significantly in liquid cultures (figure 4) making 
it difficult to obtain a turbid culture. In order to circumvent some of these difficulties we 
were able to create liquid cultures by suspending cells grown on a plate. We found that 
passing cells through a 25-gauge needle repeatedly, in new media, significantly reduced 
clumping and allowed for a liquid culture with an optical density of 0.6 at 600 nm to be 
achieved (figure 5).   
Elimination of exogenous phage particles is important to ensure that the phages 
seen on the indicator plate are from active infection of the pathogenic bacteria and not 




at a molarity of 2 mM as previously described. We have found that elimination of 
bacteriophages with FAS can be inconsistent and sometimes insufficient at 2 mM when 
infecting at a multiplicity of infection of 1. We have also noted that elimination with FAS 
may vary depending on the bacteriophage itself. As the mechanism behind inactivation 
with FAS is unknown it is difficult to determine why effectiveness could vary.  
A third variable is the time that infection is allowed to proceed. It has been 
previously reported that temperature has the ability to effect the time taken from 
attachment to lysis of the bacterial cell. Time points of 40 min and 100 min were 
routinely used in our assay. Inconsistencies in results have made it difficult to determine 
if the bacteriophage particles plated were due to amplification (lysis) of the bacterial host 
or plating of bacterial cells that have been infected. This hinders the ability of this test to 
be used in a quantifiable manner.  
Phage amplification still holds potential for testing many bacteriophages on the 
M. ulcerans host. Although results have been inconsistent, the positive control 
(mycobacteriophage D29) and negative control (mycobacteriophage Rosebush) have 
been successful multiple times (figure 7 & 8).   
Sequencing 
 Here we report on the first sequence produced on the ion torrent PGM at James 
Madison University. Of the four phages sequenced in the first two runs, Espe and IronPax 
were completely finished and annotated using the PGM sequence alone. Rover14 
assembled into a single contig, but due to the fact that the average depth of coverage was 




genome, primers have been designed for Sanger sequencing. The fourth genome Burke, 
assembled in to four contigs. After evaluation of each of the four contigs it appears that 
Burke belongs to the mycobacteriophage cluster C. Cluster C phages are relatively large 
compared to other phages with an average genome size of 155,504 base pairs. Due to the 
ISP loading densities being low for both runs (figure 9 & 11), and low final template 
library concentration with only 3.31% templated we were not able to generate 
enough depth of coverage to obtain a quality consensus sequence for the entire 
genome with an average depth of coverage of 44 reads.   
 When finishing the genomes it was also noted that strand specific insertions 
and deletions were common in all genomes. This strand bias has been noted in many 
ion torrent sequencing applications, but it has yet to be explained (Quail et al., 2012).   
Bioinformatics 
 Mycobacteriophages are known for their mosaic and diverse genomes. Here we 
report on the complete genome sequencing and annotation of two novel 
mycobacteriophages: Espe and OrionPax. Using pairwise nucleotide alignment and gene 
content analysis, Espe was determined to belong to the A1 subcluster of 
mycobacteriophages. This genome contains one novel gene, which is the basis for a new 
“orpham.”  When comparing Espe to phages of cluster A, a number of sequence repeats 
were observed.  These are consistent in terms of their genomic locations (near 21,000, 
41,000, and 47,000 base pairs) with “stoperators,” sequences that act in cis to regulate 




identified in this genome. This is typical for cluster E phages as they are highly conserved 
at the nucleotide and protein level.  
Summary 
Some cluster A, K, and G phages isolated on M. smegmatis have since been 
shown to infect M. tuberculosis or M. ulcerans (Jacobs-Sera et al., 2012; Rybniker 
J,Kramme S., Small P.L., 2005). There is a strong correlation between phage sub cluster 
and the ability to infect these alternative hosts, however this correlation is not absolute. 
Cluster A is large and diverse, with eleven sub clusters in the current database.  Genomes 
within the same sub cluster are more closely related to one another than to genomes 
withith a different sub cluster of cluster A. However, when comparing protein 
conservation within cluster A phages a much greater level of conservation is seen at both 
cluster and sub cluster designations. 
Previous data suggest that the set of phages that can replicate on M. ulcerans is 
very similar to that for M. tuberculosis.  However, we have found this not to be the case. 
Within cluster A, several bacteriophages from sub clusters A2 and A3 have the ability to 
infect M. tuberculosis and M. ulcerans. Two additional phages from the A1 cluster, Bxb1 
and U2, have also shown a limited ability to infect M. tuberculosis. Espe belongs to the 
A1 sub cluster. When comparing genomic data and preliminary amplification assay data 
for Espe, we propose that this bacteriophage may also be able to infect M. ulcerans. 
When using Phamerator maps for comparisons of Espe, Bxb1 and U2 a high level of 
conservation is observed at the protein level, especially between Espe and Bxb1. In 




observed in the region where tail fiber proteins are predicted (Figure 14). KSSJEB, 
belonging to the A1 sub cluster has not previously been shown to infect mycobacterial 
hosts. This is also consistent with the preliminary data that we have obtained using the 

























Figure 14. Conservation in the left arm of Bxb1, Espe and U2, three cluster A1 phages. Genes shown by 
boxes above the ruler are translated in the forward direction. Shading between genomes shows nucleotide 
conservation (purple being the highest degree of conservation followed by indigo, blue, green, yellow, 
orange and red being the lowest). Protein conservation is shown by the color of the boxes. Each protein 






 Although final annotations have not been completed for Rover14, we predict that 
this bacteriophage will have the ability to infect M. ulcerans due to preliminary data from 
the amplification assay and that all previously tested cluster G phages have been able to 
infect pathogenic mycobacterial hosts. While the OrionPax genome was completely 
finished, host range data is limited for cluster E phages. 
 Mycobacterial infections pose a serious health threat globally, and have a 
serious impact in many middle to low income countries. Here we propose that 
bacteriophages could offer an affordable and effective tool in combating these serious 
diseases. Not only do bacteriophages provide potential as a traditional therapeutic, 
but also could play an important role in the diagnosis of these slow-growing and 
difficult-to-diagnose diseases. In the case of Buruli ulcer the potential of a topical 
treatment could provide a unique opportunity to reintroduce phage therapy. In order 
to fulfill the potential of this large, diverse and dynamic population, investigation of 
host restriction and functionality of proteins in bacteriophage genomes must be 
completed. We hope that the amplification assay coupled with genomic analysis will 









Bhat, R. M., & Prakash, C. (2012). Leprosy: An overview of pathophysiology. 
Interdisciplinary Perspectives on Infectious Diseases, 2012, 181089. 
doi:10.1155/2012/181089; 10.1155/2012/181089 
Bickle, T. A., & Kruger, D. H. (1993). Biology of DNA restriction. Microbiological 
Reviews, 57(2), 434-450.  
Clark, J. R., & March, J. B. (2006). Bacteriophages and biotechnology: Vaccines, gene 
therapy and antibacterials. Trends in Biotechnology, 24(5), 212-218. 
doi:http://dx.doi.org/10.1016/j.tibtech.2006.03.003 
Cresawn, S., Bogel, M., Day, N., Sera, D., Hendrix, R., & Hatfull, G. (2011). Phamerator: A 
bioinformatics tool for comparative bacteriophage genomics. BMC 
Bioinformatics, 12:395, October 15, 2012. doi:10.1186/1471-2105-12-395 
Deveau, H., Barrangou, R., Garneau, J. E., Labonte, J., Fremaux, C., Boyaval, P., . . . 
Moineau, S. (2008). Phage response to CRISPR-encoded resistance in 
streptococcus thermophilus. Journal of Bacteriology, 190(4), 1390-1400. 
doi:10.1128/JB.01412-07 
Doig, K. D., Holt, K. E., Fyfe, J. A., Lavender, C. J., Eddyani, M., Portaels, F., . . . Stinear, T. P. 
(2012). On the origin of mycobacterium ulcerans, the causative agent of buruli 
ulcer. BMC Genomics, 13, 258-2164-13-258. doi:10.1186/1471-2164-13-258; 
10.1186/1471-2164-13-258 
Frampton, R., Aggio, R. B., Villas-Boas, S. G., Arcus, V. L., & Cook, G. M. (2012). Toxin-
antitoxin systems of mycobacterium smegmatis are essential for cell survival. 





George, K. M., Barker, L. P., Welty, D. M., & Small, P. L. (1998). Partial purification and 
characterization of biological effects of a lipid toxin produced by mycobacterium 
ulcerans. Infection and Immunity, 66(2), 587-593.  
Giri, N., Bhowmik, P., Bhattacharya, B., Mitra, M., & Das Gupta, S. K. (2009). The 
mycobacteriophage D29 gene 65 encodes an early-expressed protein that 
functions as a structure-specific nuclease. Journal of Bacteriology, 191(3), 959-
967. doi:10.1128/JB.00960-08; 10.1128/JB.00960-08 
Guenin-Mace, L., Simeone, R., & Demangle, C. (2009). Lipids of pathogenic 
mycobacteria: Contributions to virulence and host immune suppression. 
Transbound Emerg Dis, 56, 255-68. doi:10.1111/j.1865-1682.2009.01072.x 
Hamzat, T. K., & Boakye-Afram, B. (2011). Health-related quality of life among 
persons living with buruli ulcer in amasaman community, ga west district accra, 
ghana. Int J Health Sci, 5(1), 29-38.  
Hatful, F. G., Pedulla, L. M., Sera-Jacobs, D., Cichon, M. P., Foley, A., Ford, E. M., . . . 
Hendrix, W. R. (2006). Exploring the mycobacteriophage metaproteome: Phage 
genomics as an educational platform. PLOS, Genet, 2(6), November 8, 2012-e92. 
doi:10.1371/journal.pgen.0020092 
Henry, m., & Debarbieux, L. (2012). Tools from viruses: Bacteriophage successes and 
beyond. Virology, In press, In press. 
doi:http://dx.doi.org/10.1016/j.virol.2012.09.017 
Henry, M., O'Sullivan, O., Sleator, R. D., Coffey, A., Ross, R. P., McAuliffe, O., & O'Mahony, 




from soil. Gene, 453(1-2), 9-23. doi:10.1016/j.gene.2009.12.007; 
10.1016/j.gene.2009.12.007 
Jacobs-Sera, D., Marinelli, J. L., Bowman, C., Broussard, W. G., Bustamante, G. C., Boyle, 
M. M., . . . Hatfull, F. G. (2012). On the nature of mucobacteriophage diversity and 
host preference. Virology, in press 
doi:http://dx.doi.org/10.1016/j.virol.2012.09.026, 
Khoo, K., Suzuki, r., Dell, A., Morris, R. H., McNiel, R. M., Brennan, J. P., & Besra, S. G. 
(1996). Chemistry of the lyxose-containing mycobacteriophage receptors of 
mycobacterium phlei/mycobacterium smegmatis† - American Chemical Society. 
doi:- 10.1021/bi961055+ 
Kruger, D. H., & Bickle, T. A. (1983). Bacteriophage survival: Multiple mechanisms for 
avoiding the deoxyribonucleic acid restriction systems of their hosts. 
Microbiological Reviews, 47(3), 345-360.  
McNerney, R., Wilson, S. M., Sidhu, A. M., Harley, V. S., al Suwaidi, Z., Nye, P. M., . . . 
Stoker, N. G. (1998). Inactivation of mycobacteriophage D29 using ferrous 
ammonium sulphate as a tool for the detection of viable mycobacterium 
smegmatis and M. tuberculosis. Research in Microbiology, 149(7), 487-495.  
Meyer, J. R., Dobias, D. T., Weitz, J. S., Barrick, J. E., Quick, R. T., & Lenski, R. E. (2012). 
Repeatability and contingency in the evolution of a key innovation in phage 





Moldovan, R., Chapman-McQuiston, E., & Wu, X. L. (2007). On kinetics of phage 
adsorption. Biophysical Journal, 93(1), 303-315. 
doi:10.1529/biophysj.106.102962 
O'Brien, D. P., McDonald, A., Callan, P., Robson, M., Friedman, N. D., Hughes, A., . . . 
Athan, E. (2012). Successful outcomes with oral fluoroquinolones combined 
with rifampicin in the treatment of mycobacterium ulcerans: An observational 
cohort study. PLoS Neglected Tropical Diseases, 6(1), e1473. 
doi:10.1371/journal.pntd.0001473; 10.1371/journal.pntd.0001473 
Pedulla, M. L., Ford, M. E., Houtz, J. M., Karthikeyan, T., Wadsworth, C., Lewis, J. A., . . . 
Hatfull, G. F. (2003). Origins of highly mosaic mycobacteriophage genomes. Cell, 
113(2), 171-182. doi:http://dx.doi.org/10.1016/S0092-8674(03)00233-2 
Peeters Grietens, K., Toomer, E., Um Boock, A., Hausmann-Muela, S., Peeters, H., 
Kanobana, K., . . . Muela Ribera, J. (2012). What role do traditional beliefs play in 
treatment seeking and delay for buruli ulcer disease?--insights from a mixed 
methods study in cameroon. PloS One, 7(5), e36954. 
doi:10.1371/journal.pone.0036954; 10.1371/journal.pone.0036954 
Quail, M. A., Smith, M., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., . . . Gu, Y. 
(2012). A tale of three next generation sequencing platforms: Comparison of ion 






Richter, C., Chang, J., & Fineran, P. (2012). Function and regulation of clustered 
regularly interspaced short palindromic repeats (CRISPER) / CRISPER 
associated (cas) systems. Viruses, 10, 2291-2311. doi:10.3390/v4102291 
Rybniker J,Kramme S., Small P.L. (2005). Host range of 14 mycobacteriophages in 
mycobacterium ulcerans and seven other mycobacteria including 
mycobacterium tuberculosis--application for identification and susceptibility 
testing. Journal of Medical Microbiology, , 37-42.  
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jacobs, W. R.,Jr. (1990). Isolation 
and characterization of efficient plasmid transformation mutants of 
mycobacterium smegmatis. Molecular Microbiology, 4(11), 1911-1919.  
Stinear, T. P., Jenkin, G. A., Johnson, P. D., & Davies, J. K. (2000). Comparative genetic 
analysis of mycobacterium ulcerans and mycobacterium marinum reveals 
evidence of recent divergence. Journal of Bacteriology, 182(22), 6322-6330.  
Stinear, T. P., Mve-Obiang, A., Small, P. L., Frigui, W., Pryor, M. J., Brosch, R., . . . Cole, S. T. 
(2004). Giant plasmid-encoded polyketide synthases produce the macrolide toxin 
of mycobacterium ulcerans. Proceedings of the National Academy of Sciences of 
the United States of America, 101(5), 1345-1349. doi:10.1073/pnas.0305877101 
Stinear, T. P., Seemann, T., Pidot, S., Frigui, W., Reysset, G., Garnier, T., . . . Cole, S. T. 
(2007a). Reductive evolution and niche adaptation inferred from the genome of 
mycobacterium ulcerans, the causative agent of buruli ulcer. Genome Research, 
17(2), 192-200. doi:10.1101/gr.5942807 
Stinear, T. P., Seemann, T., Pidot, S., Frigui, W., Reysset, G., Garnier, T., . . . Cole, S. T. 




mycobacterium ulcerans, the causative agent of buruli ulcer. Genome Research, 
17(2), 192-200. doi:10.1101/gr.5942807 
Summers, W. C. (1999). Felix d' herelle and the orgins of molecular biology. New 
Haven, Connecticut: Yale University Press. 
Van der Werf, T. S., Van der Graaf, W. T., Tappero, J. W., & Asiedu, K. (1999). 
Mycobacterium ulcerans infection. The Lancet, 354(9183), 1013-1018. 
doi:10.1016/S0140-6736(99)01156-3 
Wommack, K. E., & Colwell, R. R. (2000). Virioplankton: Viruses in aquatic 
ecosystems. Microbiology and Molecular Biology Reviews : MMBR, 64(1), 69-114.  
Wong, D., Chao, J. D., & Av-Gay, Y. (2012). Mycobacterium tuberculosis-secreted 
phosphatases: From pathogenesis to targets for TB drug development. Trends in 
Microbiology, doi:10.1016/j.tim.2012.09.002; 10.1016/j.tim.2012.09.002 
World Health Organization. (2012a). Buruli ulcer (mycobacterium ulcerans infection). 
Retrieved, January 12,2013, 
World Health Organization. (2012b). Global tuberculosis report 2012- executive 
summary. (). 
Yamaguchi, Y., Park, J. H., & Inouye, M. (2011). Toxin-antitoxin systems in bacteria 
and archaea. Annual Review of Genetics, 45, 61-79. doi:10.1146/annurev-genet-
110410-132412; 10.1146/annurev-genet-110410-132412 
Yeboah-Manu, D., Peduzzi, E., Mensah-Quainoo, E., Asante-Poku, A., Ofori-Adjei, D., 
Pluschke, G., & Daubenberger, C. A. (2006). Systemic suppression of interferon-




lesions caused by the extracellular pathogen mycobacterium ulcerans. Journal of 
Leukocyte Biology, 79(6), 1150-1156. doi:10.1189/jlb.1005581 
 
